Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
LY2599506 versus glyburide in type 2 diabetes mellitus, with or without metformin
2009-016007-39Phase 2Terminated
- Sponsor
- Eli Lilly and Company
- Start
- Dec 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of LY2599506 in type 2 diabetes mellitus (T2DM) (4 arms), sponsored by Eli Lilly and Company. Primary endpoint: Change in HbA1c from baseline to 12 weeks. Started Dec 2009; status: terminated.
02
Drugs
LY2599506
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on 2009-016007-39.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2009-016007-39.